Effect of a standard dose of telmisartan combined with amlodipine and trichlormethiazide versus a high dose of telmisartan combined with trichlormethiazide on urinary excretion of albumin in hypertensive patients with type 2 diabetes mellitus.

Trial Profile

Effect of a standard dose of telmisartan combined with amlodipine and trichlormethiazide versus a high dose of telmisartan combined with trichlormethiazide on urinary excretion of albumin in hypertensive patients with type 2 diabetes mellitus.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Oct 2012

At a glance

  • Drugs Amlodipine (Primary) ; Telmisartan (Primary) ; Trichlormethiazide
  • Indications Diabetic nephropathies; Essential hypertension; Proteinuria
  • Focus Therapeutic Use
  • Acronyms ESTIMATE-A
  • Most Recent Events

    • 04 Oct 2012 Primary endpoint 'Albumin-excretion-rate' has been met.
    • 04 Oct 2012 Results presented at the 24th Scientific Meeting of the International Society of Hypertension.
    • 03 Mar 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top